AiXin Life International, Inc.
AiXin Life International, Inc. is a U.S.-listed retail drug store and proprietary store operator, but the recent excerpts provided do not include a detailed business description, product catalog, or operating summary. Based on its industry classification, the company appears to sell consumer health, wellness, and everyday retail products through store-based channels. The filings excerpted here are dominated by corporate and SEC compliance content rather than operating detail, so the company’s exact store format, brand mix, and geographic footprint are not clearly disclosed. Investors should treat the business profile as a high-level classification until more complete operating disclosures are available.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueOver-the-counter medicines, health aids, and pharmacy-adjacent consumer products sold through retail stores.
Company-branded or store-branded merchandise sold under the proprietary store format.
Vitamins, supplements, personal care, and other wellness-oriented products.
Everyday consumer staples, household items, and convenience products sold in-store.
Products
Reported · share of revenue- Manufacture and Sale53.8 %
- Hotel27.4 %
- Direct Sales11.5 %
- Pharmacies7.2 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
AiXin Life International appears to serve walk-in retail consumers who buy health, personal care, and convenience products for immediate use. The company’s likely customer base includes local households seeking routine pharmacy-adjacent purchases, as well as shoppers looking for proprietary or store-branded goods. Because the filings provided do not include segment or store-level disclosures, the exact mix of prescription, non-prescription, and general merchandise customers is not visible here. The business model suggests demand is driven by traffic, convenience, and repeat purchases rather than long-term contracts.
Buy health, wellness, and convenience products for immediate household use and routine replenishment.
Return regularly for over-the-counter medicines, personal care, and staple goods.
Buy proprietary or store-branded items when price and convenience matter more than brand preference.
Geography
The company is identified as a United States issuer, but the excerpts provided do not disclose store locations, regional sales, or country-level revenue. As a result, the geographic profile cannot be broken down reliably beyond the U.S. listing and domicile context. The absence of operating geography disclosure limits visibility into whether the business is concentrated in one state, a regional chain, or a broader national footprint. For investors, this means geographic exposure, supply chain dependence, and local market concentration remain unclear from the supplied material.
Risks
The company’s filings explicitly reference risk factors from its 2024 Form 10-K and registration statement, but the excerpt does not reproduce those risks in detail. For a retail drug store business, key risks typically include competition from larger chains, pricing pressure, inventory obsolescence, and dependence on consumer foot traffic. If the company relies on proprietary store products, it may also face sourcing, quality control, and brand acceptance risk. Because the business appears small and disclosure is limited, execution risk, liquidity risk, and concentration risk are likely more important than for a mature national chain.
A small drug store operator can be pressured on price, assortment, and convenience by national competitors with greater scale.
Exposure: Store-based consumer retail
The limited operating disclosure and small-company profile suggest higher sensitivity to working capital needs and operational missteps.
Exposure: Corporate and store operations
Retail drug and convenience goods can expire, become unsellable, or be lost through shrink, directly affecting gross margin.
Exposure: Retail inventory
If the company sells store-branded goods, it must manage supplier reliability and product quality to avoid returns and reputational damage.
Exposure: Private label / proprietary store goods
Accounting
Judgemental itemsRetail drug and convenience goods can expire or become obsolete, requiring reserves that reduce earnings.
Impact: Gross margin and operating income
Losses from theft, damage, or expiration are common in store-based retail and require management judgment.
Impact: Cost of goods sold and inventory balances
Retail demand and purchasing patterns can vary by quarter, affecting revenue and margin trends.
Impact: Interim revenue and profitability
Similar listed companies
Publicly listed companies with a comparable business focus.
Aibotics, Inc.
AIBT · Medicinal Chemicals & Botanical Products
Bioxytran, Inc
BIXT · Pharmaceutical Preparations
BioScience Health Innovations, Inc.
BHIC · Services-Computer Processing & Data Preparation
Zicix Corp
ZICX · Services-Advertising
Zicix Corp is a U.S.-based services and trading company organized around product sales and cloud services.
Annexon, Inc.
ANNX · Pharmaceutical Preparations
Agape ATP Corp
ATPC · Services-Health Services
Agape ATP Corp is a U.S.-listed health services company with a business model centered on wellness, preventive care, and related consumer health offerings.
Last updated: 24/09/2026